Jackson Hole Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Jackson Hole Capital Partners, LLC

$490 Million
Q1 2025

A detailed history of Jackson Hole Capital Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jackson Hole Capital Partners, LLC holds 34,093 shares of GILD stock, worth $3.77 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

34,093

Previous 34,574 1.39%

Holding current value

$3.77 Million

Previous $3.19 Million 19.64%

% of portfolio

0.78%

Previous 0.66%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$89.14 - $117.41 $42,876 - $56,474	-481 Reduced 1.39%	34,093 $3.82 Million
Q4 2024 Feb 07, 2025	BUY	$83.95 - $97.9 $184,773 - $215,477	2,201 Added 6.8%	34,574 $3.19 Million
Q3 2024 Oct 30, 2024	BUY	$66.59 - $83.99 $138,440 - $174,615	2,079 Added 6.86%	32,373 $2.71 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $454,553 - $524,590	7,198 Added 31.17%	30,294 $2.08 Million
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $250,816 - $305,864	3,504 Added 17.88%	23,096 $1.69 Million
Q4 2023 Feb 02, 2024	BUY	$73.27 - $83.09 $90,928 - $103,114	1,241 Added 6.76%	19,592 $1.59 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $29,206 - $31,864	395 Added 2.2%	18,351 $1.38 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $45,453 - $51,846	-598 Reduced 3.22%	17,956 $1.38 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $9,045 - $10,305	117 Added 0.63%	18,554 $1.54 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $13,087 - $18,788	-210 Reduced 1.13%	18,437 $1.58 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $13,515 - $15,438	227 Added 1.23%	18,647 $1.15 Million
Q2 2022 Jul 27, 2022	BUY	$57.72 - $65.01 $75,497 - $85,033	1,308 Added 7.64%	18,420 $1.14 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $144,742 - $181,377	2,499 Added 17.1%	17,112 $1.02 Million
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $120,157 - $136,381	1,852 Added 14.51%	14,613 $1.06 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $121,232 - $130,796	1,791 Added 16.33%	12,761 $891,000
Q2 2021 Jul 28, 2021	BUY	$63.47 - $69.35 $2,983 - $3,259	47 Added 0.43%	10,970 $755,000
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $85,140 - $97,144	1,419 Added 14.93%	10,923 $706,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $7,137 - $8,133	126 Added 1.34%	9,504 $554,000
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $30,863 - $38,805	497 Added 5.6%	9,378 $593,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $13,599 - $15,792	188 Added 2.16%	8,881 $683,000
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $79,637 - $87,906	1,274 Added 17.17%	8,693 $551,000
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $100,353 - $112,534	1,622 Added 27.98%	7,419 $501,000
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $43,771 - $49,035	700 Added 13.73%	5,797 $377,000
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $308,572 - $402,663	5,097 New	5,097 $319,000

Others Institutions Holding GILD

# of Institutions

2,289

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $139B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Hole Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Hole Capital Partners, LLC with notifications on news.

Account

Jackson Hole Capital Partners, LLC Gilead Sciences, Inc. Transaction History